Primary Care Dermatology Society
The leading primary care society for dermatology and skin surgery
 
Banner

 

PCDS Corporate Sponsors

PDF Print E-mail

Since our creation in 1981, Galderma has channelled its resources in one direction: to provide innovative therapeutic solutions that meet the needs of dermatology patients and physicians.

The effects of skin conditions reach much deeper than the skin itself. By treating and caring for the skin, we help people improve their quality of life. To achieve this, and in collaboration with our parent company L'Oréal, we pay special attention not only to the efficacy of our products, but also to their cosmetic qualities and galenic properties. This is what makes our products appealing to patients and drives our scientists to explore new areas in dermatological innovation.

Our growing portfolio includes treatment for major skin conditions – acne, rosacea, fungal nail infections, psoriasis, seborrheic dermatitis, non-melanoma skin cancer and photodamage, hyperpigmentation disorders.

Galderma UK has worked closely with some of the leading academics in dermatology to develop an integrated programme of information, education and support for healthcare professionals involved in the management of dermatology - from Consultant Dermatologists to GP's and specialists Nurses, and from Podiatrists to Pharmacists.

For a full list of the educational and support services that we support and to obtain our contact details, please visit us at www.Galderma.co.uk


LEO Pharma is a world-leading dermatology company, specialising in the research and development of innovative treatments. Owned entirely by the LEO Foundation, LEO Pharma is committed to improving patient care whilst increasing awareness and understanding within its specialist disease areas. With no shareholders, money can be reinvested into what really matters: pioneering treatment for the benefit of patients.

Spring 2007 will see the launch of the much-anticipated third module of Scratching The Surface, this time focusing on eczema. The interactive CD-Rom is even more intuitive than previous modules, featuring a wider range of case studies, with comprehensive ‘patient pathways’ facilitated by a variety of healthcare professionals. (Previous modules An Approach to the Skin Patient and Psoriasis Management are still available).

For more information about LEO Pharma and its products or educational resources, please telephone 01844 347333 or email: This e-mail address is being protected from spambots. You need JavaScript enabled to view it

Meda UK is the UK subsidiary company of Meda, a leading international speciality pharmaceutical company, originally founded in Sweden, but now with a significant company presence in 42 countries.  Meda has achieved rapid growth and profitability across  through a “search and development” acquisition strategy, creating a strong pipeline of products through partnerships and in-licensing.  Meda UK, established in 2002, is a sales and marketing-led company that has grown organically and by company acquisitions.  The company is based in Bishop’s Stortford close to Stansted airport.

Meda UK is active in: asthma, cardiology, dermatology, gastroenterology, pain management, sexual health, and women’s health.  Meda UK’s strategy is to expand via continued product and company acquisitions, strategic partnerships, and in-licensing agreements to acquire additional POM brands that complement our existing products.  Hence, further growth is planned by expanding the Meda UK franchise within the speciality sectors that make up our customer base.

 


Stiefel, a GSK company, is committed to advancing dermatology and skin science around the world in order to help people achieve healthy, beautiful skin.  Stiefel’s dedication and drive for innovation, along with its sole focus on dermatology, has established Stiefel as the world leader in the skin health industry.  To learn more about Stiefel, visit www.stiefel.com